A newly approved ‘living drug’ could save more cancer patients’ lives

Source: Science News, August 2024

Toni English’s medical team was giddy.

It was six weeks after English had completed an experimental cancer treatment, and she had arrived at the Orlando Health Cancer Institute in Florida with her husband to see the results of her latest scan.

Her team gathered in a patient exam room on the second floor of the institute. English could sense the excitement. Someone held up a phone, ready to take English’s picture. Her oncologist stood near a computer screen and pointed to an image. “Here’s the picture of your lungs before treatment,” he said. In English’s left lung, the bulbous white splotch of a tumor was clearly visible — about the size of a nectarine.
READ THE ORIGINAL FULL ARTICLE